Induction of apoptosis in mouse liver by microcystin-LR: a combined transcriptomic, proteomic, and simulation

Ting Chen1, Qingsong Wang, Jun Cui

  • 1State Key Laboratory of Pharmaceutical Biotechnology, Department of Biochemistry, Nanjing University, Nanjing 210093, China.

Insights

Microcystin-LR (MC-LR) induces liver apoptosis in mice through distinct pathways. Low doses activate the BID-BAX-BCL-2 pathway, while high doses trigger a reactive oxygen species pathway, clarifying MC-LR hepatotoxicity.

Area of Science:

  • Environmental Toxicology
  • Molecular Biology
  • Biochemistry

Background:

  • Microcystins (MCs), cyclic heptapeptide hepatotoxins from cyanobacteria, are linked to liver disease and cancer.
  • MC-LR is the most prevalent and toxic MC variant, posing risks in contaminated aquatic environments.

Purpose of the Study:

  • To elucidate the molecular mechanisms of MC-LR-induced liver apoptosis.
  • To investigate the dose-dependent effects of MC-LR on apoptotic pathways in mouse liver.

Main Methods:

  • Standard apoptotic assays (histochemistry, DNA fragmentation, flow cytometry) were employed.
  • Transcriptomic and proteomic analyses identified differentially expressed genes and proteins.
  • Computer simulations integrated multi-omics data to model apoptotic pathways.

Main Results:

  • MC-LR induced rapid, dose-dependent apoptosis in mouse liver at doses of 50-70 microg/kg.
  • Transcriptomics revealed differential expression of 61 apoptosis-related genes.
  • Proteomics identified 35 up-regulated and 30 down-regulated proteins.
  • Low-dose MC-LR induced apoptosis via the BID-BAX-BCL-2 pathway; high-dose MC-LR induced apoptosis via a reactive oxygen species pathway.

Conclusions:

  • MC-LR exposure causes apoptosis in mouse liver through distinct molecular pathways.
  • Understanding these pathways is crucial for comprehending MC-LR hepatotoxicity and tumor promotion.

Related Concept Videos